Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides

Publication | Closed Access

DOI

Citations

References

2000

Year

Douglas E Shafer, Barbara Toll, Richard F. Schuman, Brett L. Nelson, James J. Mond, Andrew Lees

Vaccine

VaccinationSelective CrosslinkingMucosal VaccinationEngineeringImmunoengineeringImmunologySoluble PolysaccharidesProtein-polysaccharide Conjugate VaccinesImmunotherapeuticsVaccine DesignMedicineBiomolecular EngineeringSynthetic Immunology